Deal will enable JRS to provide biopharma services to health science
JRS Pharma, producer of world-leading cellulose products for the health science industry, has added Celonic to its portfolio of products and services.
Celonic is a contract development and manufacturing organisation (CDMO) offering comprehensive development and manufacturing services for biotherapeutics. These services include the development of high yield production cell lines, efficient up-stream and down-stream processes, full GMP analytics, and the manufacture of active pharmaceutical ingredients (APIs) in cell culture systems at different scales of up to 1000 litres.
In addition, Celonic licenses its proprietary SEFEX (Serum Free Expression) cell line technology to clients, drug developers and other service providers.
Celonic offers a wide range of biopharma services and expertise for new biological entities, biosimilars and cell lines.